Vimarsana
Biggest News Aggregation in the World

Page 2 - Stephen Willard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Willard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Willard Today - Breaking & Trending Today

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT - Vimarsana News

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report -February 09, 2024 at 08:31 am EST - Vimarsana News

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report -February 09, 2024 at 08:31 am EST

Companies continue to work collaboratively to advance NRX-101 in bipolar depression with suicidalityLotus notes that NRx has achieved a significant milestone by completing enrollment for its phase...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination -January 17, 2024 at 06:49 am EST - Vimarsana News

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination -January 17, 2024 at 06:49 am EST

RADNOR, Pa., Jan. 17, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for suicidal depression, chronic pain, and PTSD, today...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript - Vimarsana News

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Thank you for standing by. This is the conference operator. Welcome to NRX Pharmaceuticals’ Third Quarter 2023 Earnings Conference Call. As a reminder, all participants are in listen-only mode. The conference is being recorded. After the presentation, there will be an opportunity […]

Source: yahoo.com
NRx Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

NRx Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Four near-term milestones, including initiation of potential spinout initiatives expected in 2023/early 2024 Completing enrollment of the originally-targeted...